Q32 Bio Inc. Proceeds from Issuance Initial Public Offering
Q32 Bio Inc. (FIXX) reported Proceeds from Issuance Initial Public Offering of $150.84 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2020-03-12
- Q32 Bio Inc. proceeds from issuance initial public offering for the quarter ending 2018-12-31 was $0.00.
- Q32 Bio Inc. proceeds from issuance initial public offering for the quarter ending 2018-09-30 was $0.00.
- Q32 Bio Inc. proceeds from issuance initial public offering for fiscal 2018 was $150.84M.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 6 month as first filed | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 9 month as first filed | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $150.84M 10-K · filed 2020-03-12 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $150.84M 10-Q · filed 2019-11-12 | $150.84M 10-Q · filed 2018-11-13 | |||
| 2018-06-30 | $150.84M 10-Q · filed 2019-08-08 | $150.84M 10-Q · filed 2018-08-13 |